LATEST NEWS
Evox Therapeutics enters partnership to evaluate new gene editing technology for Rett Syndrome
27 . 02 . 26
Evox Therapeutics, a biotechnology company developing innovative therapies for genetically driven neurodegenerative diseases using a next-generation gene editing modality, has announced it is initiating a collaboration with the Rett Syndrome...
Read More